| 摘要 |
<p>The present invention addresses the problem of providing a pharmaceutical for preventing and/or treating dyslipidemia. The present invention is a pharmaceutical used to prevent and/or treat dyslipidemia, the pharmaceutical containing a compound represented by general formula (I) (in the formula, R1, R2, R3, and R4 each represent a hydrogen atom, a trifluoromethyl group, or a C1-3 alkyl group) or a salt thereof as the active ingredient. Particularly preferable as the compound is (S)-N-(2-(2-(2-cyanopyrrolidine-1-yl)-2-oxoethylamino)-2-methylpropyl)-2-methylpyrazolo [1,5-a]pyrimidine-6-carboxamide (non-proprietary name: anagliptin).</p> |
